|
Stewart Hen joined Allos' Board of Directors in March 2005. He has been a partner at Warburg Pincus since 2000 and has more than 12 years experience in the biotechnology and pharmaceutical industries. Prior to joining the firm, he was a management consultant at McKinsey & Company, where he advised pharmaceutical and biotechnology companies on a range of strategic management issues. Previously, he held positions at Merck in both Research & Development and Manufacturing. Mr. Hen holds an M.B.A. from The Wharton School, where he was named a Palmer Scholar; an M.S. in chemical engineering from the Massachusetts Institute of Technology, where he was a National Science Foundation Fellow; and a B.S. in chemical engineering from the University of Delaware, where he was a DuPont Scholar. Mr. Hen is currently also a director of Altus Pharmaceuticals, Neurogen Pharmaceuticals and RibX Pharmaceuticals. He also serves on the Health Care & Sciences Group of the New York City Investment Fund. | 